Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches-Reference-Cited by-同舟云学术

Development and validation of a nomogram for assessing survival in extensive-stage small-cell lung cancer patients with superior vena cava syndrome referred for thoracic radiotherapy: a comparison of upfront vs. consolidative approaches

Published:2021-04-28 Issue:12 Volume:197 Page:1072-1083
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Mei Ting,Xiu Weigang,Yang Xuexi,Tian Xiaoman,Yu Yang,Xu Yong,Zhou Lin,Zhou Xiaojuan,Liu Yongmei,Zou Bingwen,Xue Jianxin,Ao Rui,Lu You,Gong Youling^ORCID

Funder

Department of Science and Technology of Sichuan Province

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00066-021-01783-4.pdf

Reference41 articles.

1. Kalemkerian GP (2016) Small cell lung cancer. Semin Respir Crit Care Med 37(5):783–796

2. Zhang X, Yu J, Zhu H, Meng X, Li M, Jiang L, Ding X, Sun X (2017) Consolidative thoracic radiotherapy for extensive stage small cell lung cancer. Oncotarget 8(13):22251–22261. https://doi.org/10.18632/oncotarget.14759

3. Chen Y, Li J, Hu Y, Zhang Y, Lin Z, Zhao Z, Jiao S (2016) Prophylactic cranial irradiation could improve overall survival in patients with extensive small cell lung cancer : a retrospective study. Strahlenther Onkol 192(12):905–912. https://doi.org/10.1007/s00066-016-1038-0

4. Farago AF, Keane FK (2018) Current standards for clinical management of small cell lung cancer. Transl Lung Cancer Res 7(1):69–79. https://doi.org/10.21037/tlcr.2018.01.16

5. Slotman BJ, van Tinteren H, Praag JO, Knegjens JL, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C, Senan S (2015) Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet 385(9962):36–42. https://doi.org/10.1016/S0140-6736(14)61085-0

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer;Vaccines;2024-04-29

2. A Real-World Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive Stage Small Cell Lung Cancer;2024-02-29

3. Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome;Strahlentherapie und Onkologie;2022-05-12